Cheyne Capital Management (UK)’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-63,680
Closed -$263K 36
2022
Q4
$263K Buy
+63,680
New +$263K 0.46% 50